IMVT Immunovant
Immunovant earnings company data as of 11:46 AM ET 11/17
- 1 of 1 EPS beats
History
1 period, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2027 Q2 | 9 Nov | EPS | -0.72 | -0.47 | Beat |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by IMVT's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $350M bought by 1 insider
- $10.7M sold by 5 insiders outside a trading plan
- $601K sold by 2 insiders under 10b5-1 plans
-
Atul Pande DirectorPlanned sale$108K 3,000 shares at $36.00 2.5% of stakeTraded Nov 11 Filed Nov 12
-
Atul Pande DirectorPlanned sale$65K 1,500 shares at $43.27 1.3% of stakeTraded Aug 28 Filed Aug 28
-
Atul Pande DirectorPlanned sale$60K 1,500 shares at $39.80 1.3% of stakeTraded Jul 24 Filed Jul 24
-
Melanie Gloria COOSale$679K 17,714 shares at $38.31 7.3% of stakeTraded Jun 26 Filed Jun 26
-
Jay S. Stout Chief Technology OfficerSale$1.5M 40,000 shares at $38.31 16% of stakeTraded Jun 26 Filed Jun 26
-
Christopher Van Tuyl Chief Legal OfficerSale$683K 17,824 shares at $38.31 9% of stakeTraded Jun 26 Filed Jun 26
-
Tiago Girao CFOSale$385K 10,000 shares at $38.46 3.9% of stakeTraded Jun 26 Filed Jun 26
-
Atul Pande DirectorPlanned sale$57K 1,500 shares at $38.01 1.3% of stakeTraded Jun 26 Filed Jun 26
-
Atul Pande DirectorPlanned sale$51K 1,500 shares at $34.02 1.3% of stakeTraded Jun 15 Filed Jun 16
-
Andrew J. Fromkin DirectorSale$7.4M 221,951 shares at $33.51 75% of stakeTraded May 28 Filed May 29
-
Atul Pande DirectorPlanned sale$192K 6,000 shares at $32.00 4.9% of stakeTraded May 20 Filed May 20
-
Robert Graham Susman DirectorPlanned sale$68K 2,502 shares at $27.17 6.4% of stakeTraded May 1 Filed May 1
-
Roivant Sciences Ltd. DirectorBuy$350M 16.7M shares at $21.00 +17% to stakeTraded Dec 12, 2025 Filed Dec 12, 2025
Also filed in the last 12 months, not counted as buying or selling: 45 sales to cover taxes, 15 option exercises, 11 stock grants, and 3 sales back to the company.
SEC filings
Recent issuer filings from EDGAR, 10 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon
- Financial Intelligence, Revised Ed. View on Amazon